Drägerwerk reports lower third-quarter profit: Drägerwerk stock falls 11.84 percent

Published on 10/15/2026 at 10:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q3 sales reached EUR 851.00 million on October 14, 2026. Drägerwerk stock costs EUR 102.80 on October 15, 2026, 11.84 percent below Xetra close.

Operating profit and reporting dates

Drägerwerk posted EUR 48.00 million in operating profit for the third quarter on October 14, 2026.
The company retained its 6.00 to 8.00 percent operating margin forecast for fiscal year 2026.
Drägerwerk stock trades at EUR 102.80 at 10:08 a.m. CEST at Lang & Schwarz on October 15, 2026, 11.84 percent below the Xetra close of October 14, 2026.

Isometrische 3D-Darstellung der Medizintechnik-Wertschöpfungskette von Forschung bis Einsatz — Drägerwerk AG & Co. KGaA isometrische Wertschöpfungskette Forschung Produktion Krankenhaus Sicherheitsanwendung DE0005550636, Illustration mit AI erstellt.

Drägerwerk stock (ISIN DE0005550636) was trading at EUR 102.80 at Lang & Schwarz on October 15, 2026, at 10:08 a.m. CEST, down 11.84 percent versus the Xetra close of October 14, 2026, at EUR 116.60. BÖRSE ONLINE reported on October 14, 2026, that preliminary third-quarter operating profit fell to EUR 48.00 million from EUR 56.70 million a year earlier. The figures put margin quality ahead of sales growth for investors.

Sales rise as profit slips

Revenue increased 1.00 percent on a currency-adjusted basis to EUR 851.00 million in the third quarter of 2026, compared with EUR 833.30 million in the third quarter of 2025. The operating margin declined to 5.60 percent from 6.80 percent, while EUR 20.10 million in customs refunds supported the quarter's result.

Order intake provided the stronger operating signal. It rose 7.00 percent on a currency-adjusted basis to EUR 926.00 million, with the safety division up 20.20 percent to EUR 452.00 million. Medical technology order intake fell 3.00 percent to EUR 474.00 million, creating a clear split between the two businesses.

What does the margin outlook mean?

Dräger retained its fiscal-year 2026 forecast for currency-adjusted revenue growth of 2.00 to 6.00 percent and an operating margin of 6.00 to 8.00 percent, according to BÖRSE ONLINE on October 14, 2026. The 5.60 percent quarterly margin sits below that annual range, and the customs refund is a one-off factor rather than a recurring sales driver.

Dates and valuation markers

The complete quarterly statement is scheduled for October 29, 2026, according to BÖRSE ONLINE. A ResearchHub summary dated October 9, 2026, cites an MWB Research target of EUR 130.00, raised from EUR 114.00 on August 31, 2026, and identifies November 18, 2026, as the Capital Markets Day.

Stock remains below its daily base

The current quotation is EUR 14.00 below the October 14 Xetra close, a sharper move than the revenue change in the preliminary figures. Drägerwerk's market capitalization was EUR 1.9 billion as of October 15, 2026, while the 52-week range was EUR 66.00 to EUR 125.40.

The further course of trading is shown by the continuously updated real-time quote of Drägerwerk stock.